Liver Disease Diagnostics Market in North America Market would register a CAGR of 5.8% during 2020-2026

Published Date: 16-Jul-2020

Special Offering :

Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support

According to a new report North America Liver Disease Diagnostics Market, published by KBV research, the North America Liver Disease Diagnostics Market would witness market growth of 5.8% CAGR during the forecast period (2020-2026).

The US market dominated the North America Endoscopy Market by Country in 2019, and would continue to be a dominant market till 2026. The Canada market is exhibiting a CAGR of 8.5% during (2020 - 2026). Additionally, The Mexico market would witness a CAGR of 7.5% during (2020 - 2026).

The Hospitals market dominated the Canada Liver Disease Diagnostics Market by End User in 2019, growing at a CAGR of 7.8 % during the forecast period. The Laboratories market is expected to witness a CAGR of 8.5% during (2020 - 2026).

The Imaging market dominated the Mexico Liver Disease Diagnostics Market by Diagnosis Technique in 2019, growing at a CAGR of 6.7 % during the forecast period. The Biopsy market is anticipated to witness a CAGR of 7.2% during (2020 - 2026). Additionally, The Endoscopy market would exhibit highest CAGR of 7.5% during (2020 - 2026).

Report Structural Insights: https://www.kbvresearch.com/north-america-liver-disease-diagnostics-market/

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Abbott Laboratories, F. Hoffmann-La Roche Ltd., Boston Scientific Corporation, Siemens AG (Siemens Healthineers), Bayer AG, Merck & Co., Inc., Sanofi S.A., Novartis AG, Pfizer, Inc., and Randox laboratories limited.

North America Liver Disease Diagnostics Market Segmentation

By End-User

  • Hospitals, Laboratories and Other End Users

By Diagnosis Technique

  • Imaging
  • Biopsy
  • Endoscopy
  • Laboratory tests and
  • Other Diagnosis Techniques

By Country

  • US Liver Disease Diagnostics Market
  • Canada Liver Disease Diagnostics Market
  • Mexico Liver Disease Diagnostics Market
  • Rest of North America Liver Disease Diagnostics Market

Companies Profiled

  • Abbott Laboratories
  • Hoffmann-La Roche Ltd.
  • Boston Scientific Corporation
  • Siemens AG (Siemens Healthineers)
  • Bayer AG
  • Merck & Co., Inc.
  • Sanofi S.A.
  • Novartis AG
  • Pfizer, Inc.
  • Randox laboratories limited

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Liver Disease Diagnostics Market Related Reports:

Global Market

Europe Market

Asia Pacific Market

LAMEA Market

Request For Sample


Why Choose Us

  • 24/7 Research support
    Get your queries resolved from an industry expert. Request for a free product review before report purchase.

  • Information security
    Your personal and confidential information is safe and secure.